Literature DB >> 3965040

Factors associated with duration of survival in Alzheimer's disease.

L L Barclay, A Zemcov, J P Blass, F H McDowell.   

Abstract

With a computerized data base, a data retrieval system, and a computer program using the actuarial method of life-table analysis, we compared survival rates in different subgroups of patients with dementia of the Alzheimer type (DAT; n = 199). Men (n = 71) had a shorter duration of survival than women (n = 128), with 500-day survival (mean +/- SEM) 84 +/- 5% vs. 99 +/- 3%, p less than 0.01; 1000-day survival 49 +/- 10% vs. 96 +/- 8%, p less than 0.001; 50% survival 1000 days vs. 1550 days. Patients younger than 65 years at onset had a decreased relative duration of survival compared with patients over 65 at onset, suggesting a more malignant course. Patients with a longer duration of illness tended to die sooner, but this effect was not statistically significant. The Kahn-Goldfarb mental-status quotient was not a predictor of survival. Patients with high Haycox behavioral score (greater than 20; n = 50), indicating more severe behavioral impairment, had lower survival rates at 500 days than patients with low scores (less than 12; n = 65) (80 +/- 6% vs. 95 +/- 3%, p less than 0.05). Hachinski ischemic score, measuring signs and symptoms of vascular disease, had no correlation with survival. Factors associated with decreased duration of survival in DAT include male sex, presenile onset, and increased severity of behavioral impairment.

Entities:  

Mesh:

Year:  1985        PMID: 3965040     DOI: 10.1016/0006-3223(85)90139-8

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  11 in total

1.  Predictors of mortality in patients with Alzheimer's disease living in nursing homes.

Authors:  G Gambassi; F Landi; K L Lapane; A Sgadari; V Mor; R Bernabei
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-07       Impact factor: 10.154

2.  Trajectories of behavioral disturbance in dementia.

Authors:  Tiffany W Chow; Jonathan D Fridhandler; Malcolm A Binns; Albert Lee; Jennifer Merrilees; Howie J Rosen; Robin Ketelle; Bruce L Miller
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

3.  The economic costs of Alzheimer's disease.

Authors:  J W Hay; R L Ernst
Journal:  Am J Public Health       Date:  1987-09       Impact factor: 9.308

4.  Cognitive function in the oldest old: women perform better than men.

Authors:  E van Exel; J Gussekloo; A J de Craen; A Bootsma-van der Wiel; P Houx; D L Knook; R G Westendorp
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-07       Impact factor: 10.154

5.  The US economic and social costs of Alzheimer's disease revisited.

Authors:  R L Ernst; J W Hay
Journal:  Am J Public Health       Date:  1994-08       Impact factor: 9.308

6.  Apolipoprotein E isoform-dependent effects on anxiety and cognition in female TR mice.

Authors:  Jessica A Siegel; Gwendolen E Haley; Jacob Raber
Journal:  Neurobiol Aging       Date:  2010-04-18       Impact factor: 4.673

7.  Dementia-free life expectancy in France.

Authors:  K Ritchie; J M Robine; L Letenneur; J F Dartigues
Journal:  Am J Public Health       Date:  1994-02       Impact factor: 9.308

8.  Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden.

Authors:  Gil D Rabinovici; Ansgar J Furst; Adi Alkalay; Caroline A Racine; James P O'Neil; Mustafa Janabi; Suzanne L Baker; Neha Agarwal; Stephen J Bonasera; Elizabeth C Mormino; Michael W Weiner; Maria L Gorno-Tempini; Howard J Rosen; Bruce L Miller; William J Jagust
Journal:  Brain       Date:  2010-01-15       Impact factor: 13.501

9.  Neurodegenerative Patterns of Cognitive Clusters of Early-Onset Alzheimer's Disease Subjects: Evidence for Disease Heterogeneity.

Authors:  Meredith L Phillips; Eddie C Stage; Kathleen A Lane; Sujuan Gao; Shannon L Risacher; Naira Goukasian; Andrew J Saykin; Maria C Carrillo; Bradford C Dickerson; Gil D Rabinovici; Liana G Apostolova
Journal:  Dement Geriatr Cogn Disord       Date:  2020-01-03       Impact factor: 2.959

Review 10.  Role of apolipoprotein E in anxiety.

Authors:  Jacob Raber
Journal:  Neural Plast       Date:  2007       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.